Carl Schmid has been a national policy and advocacy leader in the HIV community for over 25 years. He spent 16 years with The AIDS Institute, serving as its Deputy Executive Director. In December 2019, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. Mr. Schmid leads advocacy efforts to ensure domestic HIV and hepatitis programs are based on sound public policy and fully funded. He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of beneficiaries, including prescription medications. From December 2018 to August 2021 he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA) and Co-Chaired its Ending the HIV Epidemic Subcommittee through June 2023. He currently serves as a consumer representative to the National Association of Insurance Commissioners, a member of the NAIC/Consumer Participation Board of Trustees, and Chair of the Leadership Advisory Council for the U.S. Business Action to End HIV. He is a cancer survivor and living with chronic hepatitis B. Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.